BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34762717)

  • 1. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells.
    Adeniji OS; Kuri-Cervantes L; Yu C; Xu Z; Ho M; Chew GM; Shikuma C; Tomescu C; George AF; Roan NR; Ndhlovu LC; Liu Q; Muthumani K; Weiner DB; Betts MR; Xiao H; Abdel-Mohsen M
    PLoS Pathog; 2021 Nov; 17(11):e1010034. PubMed ID: 34762717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
    Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
    mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
    Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
    AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    Blood; 2009 Oct; 114(18):3822-30. PubMed ID: 19710502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
    Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
    Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
    Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication.
    Zhao D; Jiang X; Xu Y; Yang H; Gao D; Li X; Gao L; Ma C; Liang X
    Front Immunol; 2018; 9():1124. PubMed ID: 29899741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.
    Jandus C; Boligan KF; Chijioke O; Liu H; Dahlhaus M; Démoulins T; Schneider C; Wehrli M; Hunger RE; Baerlocher GM; Simon HU; Romero P; Münz C; von Gunten S
    J Clin Invest; 2014 Apr; 124(4):1810-20. PubMed ID: 24569453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
    Tao L; Wang S; Yang L; Jiang L; Li J; Wang X
    Clin Exp Immunol; 2020 Aug; 201(2):161-170. PubMed ID: 32319079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Developed NK-92MI Cell Line with Siglec-7
    Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.
    Belisle JA; Horibata S; Jennifer GA; Petrie S; Kapur A; André S; Gabius HJ; Rancourt C; Connor J; Paulson JC; Patankar MS
    Mol Cancer; 2010 May; 9():118. PubMed ID: 20497550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.
    Mavilio D; Lombardo G; Benjamin J; Kim D; Follman D; Marcenaro E; O'Shea MA; Kinter A; Kovacs C; Moretta A; Fauci AS
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2886-91. PubMed ID: 15699323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-7 Defines a Highly Functional Natural Killer Cell Subset and Inhibits Cell-Mediated Activities.
    Shao JY; Yin WW; Zhang QF; Liu Q; Peng ML; Hu HD; Hu P; Ren H; Zhang DZ
    Scand J Immunol; 2016 Sep; 84(3):182-90. PubMed ID: 27312286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
    Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.
    Jacobson A; Bell F; Lejarcegui N; Mitchell C; Frenkel L; Horton H
    PLoS One; 2013; 8(6):e67700. PubMed ID: 23805324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change of Siglec-9 expression in peripheral blood NK cells of SFTS patients can affect the function of NK cells.
    Zhang Y; Jin K; Dai Y; Hu N; Zhou T; Yang Z; Ding N; Zhang R; Xu R; Zhao J; Han Y; Zhu C; Zhu J; Li J
    Immunol Lett; 2023 Nov; 263():97-104. PubMed ID: 37865296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.
    Ward J; Bonaparte M; Sacks J; Guterman J; Fogli M; Mavilio D; Barker E
    Blood; 2007 Aug; 110(4):1207-14. PubMed ID: 17513617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Frequency of Dysfunctional Siglec-7
    Sakamoto Y; Yoshio S; Doi H; Mori T; Matsuda M; Kawai H; Shimagaki T; Yoshikawa S; Aoki Y; Osawa Y; Yoshida Y; Arai T; Itokawa N; Atsukawa M; Ito T; Honda T; Mise Y; Ono Y; Takahashi Y; Saiura A; Taketomi A; Kanto T
    Front Immunol; 2021; 12():603133. PubMed ID: 33692781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.